More importantly, we showed that Ki-67 modulation during NACT has remarkable prognostic value in patients with ER+HER2− BC and TNBC failing to achieve pCR, and we identified and validated cut-off values for relative change of Ki-67 expression as an alternative approach to stratify patients after NACT. This evidence concerns the gene ESR1 and breast cancer.